Syndrome of inappropriate antidiuretic hormone secretion (SIADH) in patients with limited stage small cell lung cancer
Authors:
- Patricia TaiPatricia Tai
- Edward YuEYEdward Yu
- Kurian JonesKJKurian Jones
- Evgeny SadikovESEvgeny Sadikov
- Shazia MahmoodSMShazia Mahmood
- Jon TonitaJTJon Tonita
- 1 August 2006
- journal article
- Published by Elsevier in Lung Cancer
- Vol. 53 (2) , 211-215
Abstract
No abstract availableKeywords
This publication has 7 references indexed in Scilit:
- Twenty-year follow-up study of long-term survival of limited-stage small-cell lung cancer and overview of prognostic and treatment factorsInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2003
- Cisplatin and Etoposide Regimen Is Superior to Cyclophosphamide, Epirubicin, and Vincristine Regimen in Small-Cell Lung Cancer: Results From a Randomized Phase III Trial With 5 Years’ Follow-UpJournal of Clinical Oncology, 2002
- The syndrome of inappropriate secretion of antidiuretic hormone (SIADH) in small-cell lung cancer.Journal of Clinical Oncology, 1986
- A retrospective study of thirty-two patients with small-cell bronchogenic carcinoma and inappropriate secretion of antidiuretic hormoneClinical Radiology, 1986
- Management of the syndrome of inappropriate antidiuretic hormone secretion in small cell lung cancerCancer, 1983
- The frequency and clinical biology of the ectopic hormone syndromes of small cell carcinomaCancer, 1982
- Small cell carcinoma: combined approach to treatment.Thorax, 1979